Altus Pharmaceuticals Inc. 4
4 · Altus Pharmaceuticals Inc. · Filed Dec 22, 2006
Insider Transaction Report
Form 4
Berkle Sheldon
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2006-12-22$3.92/sh+8,000$31,360→ 8,000 total - Exercise/Conversion
Common Stock Option (Right to buy)
2006-12-22−8,000→ 532,943 totalExercise: $3.92From: 2005-05-09Exp: 2015-05-08→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]One quarter of these options will vest on May 9, 2006, and thereafter an additional 1/48th of the total underlying option grant vests on a monthly basis, such that all options will be vested after four years. In addition, all of these options are immediately exercisable for shares of restricted stock, which are subject to a repurchase right by the Issuer that lapses based on the vesting schedule set forth in the previous sentence.